Literature DB >> 19082255

[An evaluation of a continuing medical education program for primary care services in the prescription of hypoglycemic agents in diabetes mellitus type 2].

Angélica Castro-Ríos1, Hortensia Reyes-Morales, Ricardo Pérez-Cuevas.   

Abstract

OBJECTIVE: To evaluate the impact of a continuing medical education program on family doctors to improve prescription of hypoglycemic drugs.
MATERIAL AND METHODS: An observational study was conducted with two groups of comparison (with-without program) and before-after periods. The unit of analysis was the visit. The period of evaluation comprised six months before and six after implementing the program. The outcome variable was the appropriateness of prescription that was based upon two criteria: appropriate selection and proper indication of the drug. Logistic regression models and the double differences technique were used to analyze the information. Models were adjusted by independent variables related with the patient, the visit and the PCC, the more relevant ones were: sex, obesity, conditions other than diabetes, number of visits in the analyzed period, number of drugs prescribed, size of the PCC and period.
RESULTS: the program increases 0.6% the probability of appropriate prescription and 11% the probability of appropriate choice of the hypoglycemic drug in obese patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082255     DOI: 10.1590/s0036-36342008001000005

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  2 in total

1.  Physicians and pharmacists: collaboration to improve the quality of prescriptions in primary care in Mexico.

Authors:  Dolores Mino-León; Hortensia Reyes-Morales; Luis Jasso; Svetlana Vladislavovna Douvoba
Journal:  Int J Clin Pharm       Date:  2012-04-17

Review 2.  [Effectiveness of interventions for improving drug prescribing in Primary Health Care].

Authors:  Marco Antonio Zavala-González; Carlos Enrique Cabrera-Pivaral; María de Jesús Orozco-Valerio; Igor Martín Ramos-Herrera
Journal:  Aten Primaria       Date:  2016-06-11       Impact factor: 1.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.